IN-VITRO AND IN-VIVO ENHANCEMENT OF DDI-ACTIVITY AGAINST RAUSCHER MURINE LEUKEMIA-VIRUS BY RIBAVIRIN

被引：5

作者：

ALLEN, LB ^{[1
]}

QUENELLE, DC ^{[1
]}

WESTBROOK, L ^{[1
]}

TAYLOR, BA ^{[1
]}

PRICHARD, MN ^{[1
]}

BRAZIER, AD ^{[1
]}

HOLLINGSHEAD, MG ^{[1
]}

SHANNON, WM ^{[1
]}

机构：

[1] STANFORD UNIV,DEPT MICROBIOL & IMMUNOL,STANFORD,CA 94305

来源：

ANTIVIRAL RESEARCH | 1995年 / 27卷 / 03期

关键词：

RAUSCHER MURINE LEUKEMIA VIRUS; RIBAVIRIN; DIDEOXYINOSINE; ENHANCEMENT;

D O I：

10.1016/0166-3542(95)00018-H

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Ribavirin has been reported to enhance the activity of ddI against HIV. We explored this enhancement of antiviral activity in Rauscher murine leukemia virus (RMuLV) models in vitro and in vivo. The significant finding in these studies was that combinations of the drugs exhibited virus titer reductions that were greater than would be expected if the drug interactions were simply additive. These effects were designated synergistic by the method of Prichard and Shipman (Prichard, M.N. and Shipman, C., Jr. (1990) A three-dimensional model to analyze drug-drug interactions, Antiviral Res. 14, 181-206). In addition to the antiviral synergy, we also observed some synergistic toxicity in the animal model.

引用

页码：317 / 323

页数：7

共 11 条

[1]

Allen, Vanderslice, Fingal, McCright, Harris, Cook, Evaluation of the anti-herpesvirus drug combinations: virazole plus arabinofuranosyl-hypoxanthine and virazole plus arabinofuranosyladenine, Antiviral Res., 2, pp. 203-216, (1982)

[2]

Baba, Pauwels, Balzarini, Herdewijn, De Clercq, Sesmyter, Ribavirin antagonizes inhibitory effects of pyrimidine 2′,3′-dideoxynucleosides but enhances inhibitory effects of purine 2′,3′-dideoxynucleosides on replication of human immunodeficiency virus in vitro, Antimicrob. Agents Chemother., 31, pp. 1613-1617, (1987)

[3]

Balzarini, Naesen, Robins, De Clercq, Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2′,3′-dideoxyinosine and 2′, 3′-dideoxy-2,6-diaminopurine riboside, J. Acquired Immune Defic. Syndr., 3, pp. 1140-1147, (1990)

[4]

Balzarini, Lee, Herdewijn, De Clercq, Mechanism of the potentiating effect of ribavirin on the activity of 2′,3′-dideoxyinosine against human immunodeficiency virus, Biol. Chem., 266, pp. 21509-21514, (1991)

[5]

Bondoc, Robbins, Ahluwalia, Mitsuya, Johns, Fridland, Modulation of metabolism and anti-HIV-1 activity of purine 2′,3′-dideoxynucleosides by IMP dehydrogenase inhibitors, Adv. Exp. Med. Biol., 309 A, pp. 49-53, (1991)

[6]

Hollingshead, Westbrook, Ross, Bailey, Qualls, Allen, An ELISA system for evaluating antiretroviral activity against Rauscher murine leukemia virus, Antiviral Res., 18, pp. 267-274, (1992)

[7]

Prichard, Shipman, A three-dimensional model to analyze drug-drug interactions, Antiviral Res., 14, pp. 181-206, (1990)

[8]

Rowe, Pugh, Hartley, Plaque assay techniques for murine leukemia viruses, Virology, 42, pp. 1136-1139, (1970)

[9]

Shannon, Antiretroviral activity of carbocyclic nucleoside analogs, Advances in Chemotherapy of AIDS, pp. 75-95, (1990)

[10]

Shannon, Brockman, Westbrook, Shaddix, Schabel, Inhibition of Gross leukemia virus-induced plaque formation in XC cells by 3-deazauridine, J. Natl. Cancer Inst., 52, pp. 199-205, (1974)

← 1 2 →